🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 5 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/04/2000 | 68,70 | 68,88 | 67,03 | 68,64 | -0,78% | 2,69% | 4.841.131 |
| 25/04/2000 | 68,64 | 69,48 | 66,67 | 69,18 | +0,78% | 4,08% | 7.010.177 |
| 24/04/2000 | 66,67 | 68,88 | 66,56 | 68,64 | +3,14% | 3,49% | 7.771.758 |
| 20/04/2000 | 65,84 | 67,03 | 65,78 | 66,56 | +1,09% | 1,90% | 6.856.016 |
| 19/04/2000 | 62,98 | 66,56 | 62,56 | 65,84 | +4,15% | 6,34% | 8.569.182 |
| 18/04/2000 | 61,31 | 63,33 | 61,07 | 63,22 | +2,81% | 3,70% | 4.821.534 |
| 17/04/2000 | 60,83 | 61,78 | 59,04 | 61,49 | +1,38% | 4,51% | 6.561.633 |
| 14/04/2000 | 61,96 | 62,62 | 59,70 | 60,65 | -3,42% | 4,72% | 6.451.069 |
| 13/04/2000 | 62,38 | 63,93 | 62,14 | 62,80 | +1,45% | 2,87% | 5.105.542 |
| 12/04/2000 | 64,47 | 64,65 | 61,90 | 61,90 | -3,62% | 4,26% | 6.120.425 |
| 11/04/2000 | 63,39 | 64,89 | 63,33 | 64,23 | +1,41% | 2,45% | 5.979.783 |
| 10/04/2000 | 62,08 | 65,12 | 62,08 | 63,33 | +1,34% | 4,90% | 4.936.918 |
| 07/04/2000 | 62,38 | 63,63 | 62,02 | 62,50 | -0,10% | 2,58% | 3.481.875 |
| 06/04/2000 | 63,93 | 63,99 | 61,67 | 62,56 | -3,94% | 3,64% | 6.526.944 |
| 05/04/2000 | 64,83 | 65,36 | 63,87 | 65,12 | +0,83% | 2,30% | 6.547.485 |
| 04/04/2000 | 65,18 | 66,56 | 62,26 | 64,59 | +1,40% | 6,59% | 12.605.134 |
| 03/04/2000 | 59,52 | 63,93 | 59,52 | 63,69 | +7,44% | 7,41% | 8.014.266 |
| 31/03/2000 | 60,89 | 61,96 | 59,28 | 59,28 | -3,02% | 4,41% | 5.934.405 |
| 30/03/2000 | 61,07 | 62,92 | 60,89 | 61,13 | +0,10% | 3,32% | 6.606.173 |
| 29/03/2000 | 60,05 | 62,02 | 59,64 | 61,07 | +3,96% | 3,97% | 7.385.466 |
| 28/03/2000 | 57,01 | 59,64 | 57,01 | 58,74 | +0,72% | 4,60% | 7.956.416 |
| 27/03/2000 | 58,09 | 58,74 | 57,13 | 58,33 | -1,01% | 2,77% | 5.846.268 |
| 24/03/2000 | 60,00 | 60,11 | 57,61 | 58,92 | -1,79% | 4,18% | 7.016.989 |
| 23/03/2000 | 60,65 | 61,78 | 59,70 | 60,00 | -2,42% | 3,44% | 5.059.849 |
| 22/03/2000 | 60,17 | 61,96 | 60,11 | 61,49 | +0,78% | 3,07% | 5.527.362 |
| 21/03/2000 | 58,80 | 61,07 | 58,74 | 61,01 | +3,75% | 3,96% | 5.390.283 |
| 20/03/2000 | 58,80 | 59,34 | 57,55 | 58,80 | -1,79% | 3,04% | 6.412.398 |
| 17/03/2000 | 61,96 | 62,02 | 59,82 | 59,88 | -3,46% | 3,56% | 8.924.139 |
| 16/03/2000 | 57,67 | 62,68 | 57,43 | 62,02 | +8,67% | 9,10% | 15.846.598 |
| 15/03/2000 | 53,67 | 57,25 | 53,49 | 57,07 | +5,86% | 7,00% | 9.626.509 |